Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma
Authors
Keywords
MicroRNA-141, Pancreatic ductal adenocarcinoma, YAP1, Prognosis
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 388, Issue 1-2, Pages 39-49
Publisher
Springer Nature
Online
2013-11-16
DOI
10.1007/s11010-013-1897-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNAs in Metabolic Disease
- (2013) Carlos Fernández-Hernando et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- An Update on Molecular Research of Pancreatic Adenocarcinoma
- (2012) Christian Krautz et al. Anti-Cancer Agents in Medicinal Chemistry
- MicroRNAs as potential biomarkers in human solid tumors
- (2012) Jun Shen et al. CANCER LETTERS
- Role of miRNAs in Muscle Stem Cell Biology: Proliferation, Differentiation and Death
- (2012) Stefania Crippa et al. CURRENT PHARMACEUTICAL DESIGN
- Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer
- (2012) Yan Jia et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- A Possible Role for MicroRNA-141 Down-Regulation in Sunitinib Resistant Metastatic Clear Cell Renal Cell Carcinoma Through Induction of Epithelial-to-Mesenchymal Transition and Hypoxia Resistance
- (2012) Joost Berkers et al. JOURNAL OF UROLOGY
- Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells
- (2012) Caroline H. Diep et al. PLoS One
- Structures of YAP protein domains reveal promising targets for development of new cancer drugs
- (2012) Marius Sudol et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Clinical implications of biological markers in pancreatic ductal adenocarcinoma
- (2012) Francesco Giovinazzo et al. SURGICAL ONCOLOGY-OXFORD
- Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer
- (2011) Jason C. Gonzales et al. Clinical Genitourinary Cancer
- MicroRNA functional network in pancreatic cancer: From biology to biomarkers of disease
- (2011) Jin Wang et al. JOURNAL OF BIOSCIENCES
- MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma
- (2011) Yukako Imanaka et al. JOURNAL OF HUMAN GENETICS
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- (2011) Hanyin Cheng et al. PLoS One
- Roles and Mechanisms of MicroRNAs in Pancreatic Cancer
- (2011) Lidong Zhang et al. WORLD JOURNAL OF SURGERY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- MicroRNA-141 Regulates Smad Interacting Protein 1 (SIP1) and Inhibits Migration and Invasion of Colorectal Cancer Cells
- (2009) Minghua Hu et al. DIGESTIVE DISEASES AND SCIENCES
- Down-regulation of miR-141 in gastric cancer and its involvement in cell growth
- (2009) Ying Du et al. JOURNAL OF GASTROENTEROLOGY
- Yes-associated protein (YAP) functions as a tumor suppressor in breast
- (2008) M Yuan et al. CELL DEATH AND DIFFERENTIATION
- miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
- (2008) Zhiyu Zhang et al. LABORATORY INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started